Domain metastability: A molecular basis for immunoglobulin deposition?

Journal of Molecular Biology

Volumn 399, Issue 2, 2010, Pages 207-213

  Sonnen, Andreas F P ^a   Yu, Chao ^b   Evans, Edward J ^b   Stuart, David I ^a   Davis, Simon J ^b   Gilbert, Robert J C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Amyloid; CTLA 4; Electron microscopy; Protein aggregation assays; X ray crystallography

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; IMMUNOGLOBULIN LIGHT CHAIN;

ARTICLE; BETA SHEET; CRYSTAL STRUCTURE; DISULFIDE BOND; HETEROLOGOUS EXPRESSION; HYDROGEN BOND; IMMUNOGLOBULIN DEPOSITION; IMMUNOGLOBULIN STRUCTURE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; STRUCTURE ANALYSIS; ULTRASTRUCTURE;

EID: 77953082562     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2010.04.011     Document Type: Article

References (23)

1. Bennett M.J., Sawaya M.R., Eisenberg D. Deposition diseases and 3D domain swapping. Structure 2006, 14:811-824.
2. Schwartz J.C., Zhang X., Fedorov A.A., Nathenson S.G., Almo S.C. Structural basis for co-stimulation by the human CTLA-4/B7-2 complex. Nature 2001, 410:604-608.
3. Stamper C.C., Zhang Y., Tobin J.F., Erbe D.V., Ikemizu S., Davis S.J., et al. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature 2001, 410:608-611.
4. Evans E.J., Esnouf R.M., Manso-Sancho R., Gilbert R.J.C., James J.R., Yu C., et al. Crystal structure of a soluble CD28-Fab complex. Nat. Immunol. 2005, 6:271-279.
5. Davis S.J., van der Merwe P.A. The kinetic segregation model: TCR triggering and beyond. Nat. Immunol. 2006, 7:803-809.
6. Schoenfeld D., Matschiner G., Chartwell L., Trentmann S., Gille H., Huelsmeyer M., et al. An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies. Proc. Nat'l Acad. Sci. USA 2009, 106:8198-8203.
7. Ostrov D.A., Shi W., Schwartz J.C., Almo S.C., Nathenson S.G. Structure of murine CTLA-4 and its role in modulating T cell responsiveness. Science 2000, 290:816-819.
8. Hatherley D., Graham S.C., Turner J., Harlos K., Stuart D.I., Barclay A.N. Paired receptor specificity explained by structures of signal receptor proteins alone and complexed with CD47. Mol. Cell 2008, 31:266-277.
9. Spinelli S., Desmyter A., Frenken L., Verrips T., Tegoni M, Cambillau C Domain swapping of a llama VHH domain builds a crystal-wide beta-sheet structure. FEBS Lett. 2004, 564:35-40.
10. Wright C.F., Teichmann S.A., Clarke J., Dobson C.M. The importance of sequence diversity in the aggregation and evolution of proteins. Nature 2005, 438:878-881.
11. Padrick S.B., Miranker A.D. Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. Biochemistry 2002, 41:4694-6703.
12. Galkin O., Pan W., Filobelo L., Hirsch R.E., Nagel R.L., Vekilov P.G Two-step mechanism of homogeneous nucleation of sickle cell hemoglobin polymers. Biophys. J. 2007, 93:902-913.
13. Oaks M.K., Hallett K.M., Penwell R.T., Stauber E.C., Warren S.J., Tector A.J. A native soluble form of CTLA-4. Cell. Immunol. 2000, 201:144-153.
14. Oaks M.K., Hallett K.M. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J. Immunol. 2000, 164:5015-5018.
15. Wang X.B., Kakoulidou M., Giscombe R., Qiu Q., Huang D., Pirskanen R., Lefvert A.K. Abnormal expression of CTLA-4 by T cells from patients with myasthenia gravis: effect of an AT-rich gene sequence. J. Neuroimmunol. 2002, 130:224-232.
16. Liu M.F., Wang C.R., Chen P.C., Fung L.L. Increased expression of soluble cytotoxic T-lymphocyte-associated antigen-4 molecule in patients with systemic lupus erythematosus. Scand. J. Immunol. 2003, 57:568-572.
17. Sato S., Fujimoto M., Hasegawa M., Komura K., Yanaba K., Hayakawa I., et al. Serum soluble CTL:A-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) 2004, 43:1261-1266.
18. Murray A.J., Lewis S.J., Barclay A.N., Brady R.L. One sequence, two folds: a metastable structure of CD2. Proc. Natl Acad. Sci. USA 1995, 92:7337-7341.
19. Cox G.N., Pratt D., Smith D., McDermott M.J., Vanderslice R.W. Refolding and characterisation of recombinant human CTLA-4 expressed in Escherichia coli. Protein Expr. Purif. 1999, 17:26-32.
20. Chiti F., Webster P., Taddei N., Clark A., Stefani M., Ramponia G., Dobson C.M. Designing conditions or in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA 1999, 96:3590-3594.
21. Kabsch W. Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants. J. Appl. Crystallogr. 1993, 26:795-800.
22. McCoy A.J. Solving structures of protein complexes by molecular replacement with Phaser. Acta Crystallogr., Sect. D: Biol. Crystallogr. 2007, 63:32-41.
23. Winn M.D., Murshudov G.N., Papiz M.Z. Macomolecular TLS refinement in REFMAC at moderate resolutions. Methods Enzymol. 2003, 374:300-321.